We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+5.3%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$5.53B
AUM Growth
+$159M
Cap. Flow
-$12.4M
Cap. Flow %
-0.22%
Top 10 Hldgs %
20.92%
Holding
797
New
64
Increased
251
Reduced
262
Closed
82

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$55.7M
2
ITC
ITC HOLDINGS CORP
ITC
+$38.9M
3
AGN
Allergan Inc
AGN
+$38.3M
4
ACN icon
Accenture
ACN
+$37.2M
5
TSLA icon
Tesla
TSLA
+$35.7M

Sector Composition

Rank Sector Weight
1 Healthcare 19.43%
2 Financials 16.55%
3 Consumer Discretionary 12.19%
4 Industrials 12.01%
5 Technology 10.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DE icon
226
Deere & Co
DE
$168B
$1.5M 0.03%
17,116
+141
+0.8% +$12.5K
ANSS
227
DELISTED
Ansys
ANSS
$1.48M 0.03%
16,825
-4,410
-21% -$373K
LLY icon
228
Eli Lilly
LLY
$1.05T
$1.48M 0.03%
20,399
+1,655
+9% +$118K
BLK icon
229
Blackrock
BLK
$181B
$1.48M 0.03%
4,036
+8
+0.2% +$2.9K
VFC icon
230
VF Corp
VFC
$5.36B
$1.47M 0.03%
20,671
+96
+0.5% +$6.65K
AEK.CL
231
DELISTED
Aegon NV
AEK.CL
$1.47M 0.03%
51,566
-1,000
-2% -$28.4K
YUM icon
232
Yum! Brands
YUM
$41.1B
$1.46M 0.03%
25,861
-1,912
-7% -$104K
USB icon
233
US Bancorp
USB
$97.2B
$1.44M 0.03%
33,067
+4,889
+17% +$214K
VB icon
234
Vanguard Morningstar Small-Cap ETF
VB
$82.2B
$1.44M 0.03%
11,784
+3,303
+39% +$391K
SYK icon
235
Stryker
SYK
$124B
$1.44M 0.03%
15,636
+1,705
+12% +$159K
CP icon
236
Canadian Pacific Kansas City
CP
$82.5B
$1.44M 0.03%
39,400
-2,290
-5% -$84.5K
NSC icon
237
Norfolk Southern
NSC
$78.1B
$1.4M 0.03%
13,635
-50
-0.4% -$5.35K
VNRBP
238
DELISTED
Vanguard Natural Resources LLC 7.625% Series B Cumulative Redeemable Perpetual Preferred Unit
VNRBP
$1.35M 0.02%
62,770
+5,320
+9% +$114K
FAST icon
239
Fastenal
FAST
$58.7B
$1.35M 0.02%
129,948
-464
-0.4% -$5.01K
IVR.PRB
240
DELISTED
INVESCO MORTGAGE CAPITAL INC. 7.75% Fixed-To-Floating Series B Cumulative Redeemable Preferred Stock
IVR.PRB
$1.34M 0.02%
54,700
+8,400
+18% +$204K
IBN icon
241
ICICI Bank
IBN
$107B
$1.33M 0.02%
141,159
+3,576
+3% +$37.1K
MRK icon
242
Merck
MRK
$369B
$1.32M 0.02%
24,157
-617
-2% -$34.9K
LVS icon
243
Las Vegas Sands
LVS
$28.7B
$1.31M 0.02%
23,791
-19
-0.1% -$1.06K
PLL
244
DELISTED
PALL CORP
PLL
$1.31M 0.02%
13,005
-414
-3% -$41.8K
BKD icon
245
Brookdale Senior Living
BKD
$2.89B
$1.3M 0.02%
34,365
-2,495
-7% -$91.4K
LKQ icon
246
LKQ Corp
LKQ
$6.42B
$1.28M 0.02%
50,110
-845
-2% -$21.9K
PANW icon
247
Palo Alto Networks
PANW
$312B
$1.26M 0.02%
51,690
-21,930
-30% -$491K
LAZ icon
248
Lazard
LAZ
$4.21B
$1.25M 0.02%
23,700
-4,993
-17% -$246K
CL icon
249
Colgate-Palmolive
CL
$72.5B
$1.24M 0.02%
17,830
-2,045
-10% -$141K
JEF icon
250
Jefferies Financial Group
JEF
$12.2B
$1.23M 0.02%
61,560
+4,315
+8% +$89.2K

Similar funds

Geneva Advisors's Q1 2015 Portfolio in Review

As of Q1 2015, Geneva Advisors held 797 positions worth $5.53B, up 3% from $5.37B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Geneva Advisors's Q1 2015 filing shows 64 new, 251 increased, 262 reduced and 82 closed positions. Its largest new stake was Ulta Beauty: 303,437 shares worth $45.8M. The largest sale was Johnson & Johnson, an estimated $55.7M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Geneva Advisors's largest Q1 2015 buy was Ulta Beauty: 303,437 shares worth $45.8M.
  • Geneva Advisors added most to CF Industries in Q1 2015, an estimated $41.4M increase.
  • Geneva Advisors's biggest Q1 2015 reduction was Johnson & Johnson, cutting an estimated $55.7M.
  • Geneva Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $38.3M.
  • Geneva Advisors's ten largest holdings make up 21% of its $5.53B portfolio in Q1 2015.
  • Geneva Advisors opened 64 new positions and closed 82 in Q1 2015.
  • Geneva Advisors's portfolio value rose 3% quarter-over-quarter to $5.53B.

Based on Geneva Advisors's 13F filing for Q1 2015, filed 5 May 2015.